Anxiety Disorders Treatment Market, by drug category (SSRIs, TCAs, SNRIs, MAOIs, Anticonvulsants, and Others), therapy (TMS, ECT, CBT, FWS, and Others), and Geography (North America, Europe, Asia Pacific, And Rest Of The World) Analysis, Share, Trends, Size, & Forecast From 2016 2027- COVID- 19 Updated
- Published Date: 2020-10-13
- Report ID: 1779
- Pages: 206
-
Format:
REPORT HIGHLIGHT
The anxiety disorders & depression treatment market is estimated to represent a global market of USD 16.6 billion by 2019 with growth rate of 2.2%.
Anxiety is defined as an excessive fear of a normal situation or an exaggerated response to a fear. Anxiety is one of the fast spreading disorder across the globe, majorly among young population. However, people often live with anxiety problem for years before they diagnose or treat with the condition which would in turn hamper the market growth to some extent. According to the American Psychiatric Association, anxiety can be categorized into phobias, acute stress disorder, panic disorder, obsessive-compulsive disorder, generalized anxiety disorder, and post-traumatic stress disorder.
Increasing prevalence of anxiety related disorders has led to high clinical urgency for adoption of various therapies and therapeutics available in the market, which is anticipated to fuel growth over the coming years. As per World Health Organization (WHO), anxiety and other form of depressions are one of the most common mental disorders affecting more than 300 million people worldwide. The number is projected to increase at constant rate during the forecast period.
COVID-19 Impact & Recovery Analysis
The proposed report from AnalystView Market Insights suggests three possible forecast scenarios (probable, optimistic, and pessimistic) considering the COVID-19 impact. Our ongoing research analysis amplifies our framework to ensure the inclusion of underlying COVID-19 crisis impact and potential paths forward. The designed report is delivering detailed insights on COVID-19 considering the changes in consumer demand, purchasing patterns, re-routing of the supply chain, and the significant interventions of governments. The updated study provides insights, and forecast, considering the COVID-19 impact on the market.
In terms of drug category, the market is divided into Selective Serotonin Reuptake Inhibitors (SSRIs), Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Monoamine oxidase inhibitors (MAOIs), Anticonvulsants, and Others. Among which, SSRIs and SNRIs are contributed to largest market share, capturing almost 60% share of the global market. Furthermore, segments such as beta blockers, SSRIs and others are considered to be the highest growing market segment during the coming years. This upsurge is a consequence of high stress and competitive work environment coupled with unprecedented shift in the lifestyle, such as drinking, smoking, consumption of unhealthy food, etc.
Regionally, developed countries of North America and Europe dominated the market, captured more than 70% share of the global market. Boost in research and development activities by key operating companies to introduce novel anxiety therapeutics and therapies coupled with surge in demand for effective anxiety therapeutics among end-users drives the market growth.
Furthermore, large number of therapeutics under clinical investigation in North America & Europe further support the market growth. For example, Switzerland based Adde Therapeutics initiated multi-centric, double-blinded, Phase II tiral of ADX71149 in adults affected with major depressive disorder in collaboration with Janssen Pharmaceuticals, Inc. These types of initiatives will support the market growth to great extent.
The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.
The years considered for the study are:
Historical Year 2016 to 2018
Base Year 2019
Estimated Year 2020
Projected Year 2027
The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ANXIETY DISORDERS & DEPRESSION TREATMENT MARKET, BY DRUG CATEGORY
Selective Serotonin Reuptake Inhibitors (SSRIs)
Tricyclic Antidepressants (TCAs)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Monoamine oxidase inhibitors (MAOIs)
Anticonvulsants
Others
GLOBAL ANXIETY DISORDERS & DEPRESSION TREATMENT MARKET, BY THERAPY
Transcranial Magnetic Stimulator (TMS)
Electroconvulsive Therapy (ECT)
Cognitive Behaviour Therapy (CBT)
Fischer Wallace Stimulator
Others
GLOBAL ANXIETY DISORDERS & DEPRESSION TREATMENT MARKET, BY REGION
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
TABLE OF CONTENTS
ANXIETY DISORDER TREATMENT MARKET OVERVIEW
Study Scope
Base Year
Assumption and Methodology
EXECUTIVE SUMMARY
Key Market Facts
Geographical Scenario
Companies in the Market
ANXIETY DISORDER TREATMENT KEY MARKET TRENDS
Market Drivers
Impact Analysis of Market Drivers
Market Restraints
Impact Analysis of Market Restraints
Market Opportunities
Market Future Trends
ANXIETY DISORDER TREATMENT INDUSTRY STUDY
Company Activity Analysis
Regulatory Framework Analysis
Value Chain Analysis
ANXIETY DISORDER TREATMENT MARKET LANDSCAPE
Market Share Analysis
Key Innovators
ANXIETY DISORDER TREATMENT MARKET BY DRUG CATEGORY:
Overview
Serotonin Reuptake Inhibitors (SSRIs)
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Tricyclic Antidepressants (TCAs)
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Monoamine oxidase inhibitors (MAOIs)
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Anticonvulsants
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Others
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
ANXIETY DISORDER TREATMENT MARKET BY THERAPY:
Overview
Transcranial Magnetic Stimulator
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Electroconvulsive Therapy (ECT)
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Cognitive Behaviour Therapy (CBT)
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Fischer Wallace Stimulator
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Others
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
ANXIETY DISORDER TREATMENT MARKET BY GEOGRAPHY
Introduction
North America
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
S.
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Canada
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Europe
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
France
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Germany
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Rest of Europe
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Asia Pacific (APAC)
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
China
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
India
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Rest of APAC
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Rest of the World
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Latin America
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Middle East and Africa
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
KEY VENDOR ANALYSIS
Eli Lily & Company
Company Overview
SWOT Analysis
Key Developments
Bristol-Myers Squibb Company
Company Overview
SWOT Analysis
Key Developments
AstraZeneca plc
Company Overview
SWOT Analysis
Key Developments
Johnson & Johnson
Company Overview
SWOT Analysis
Key Developments
GlaxoSmithKline
Company Overview
SWOT Analysis
Key Developments
Pfizer, Inc.
Company Overview
SWOT Analysis
Key Developments
360 DEGREE ANALYSTVIEW
APPENDIX
Research Methodology
Abbreviations
Disclaimer
Contact Us
SCOPE AND OBJECTIVES
The objective of this report is to describe the market trends and revenue forecasts for the ANXIETY DISORDER TREATMENT Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the ANXIETY DISORDER TREATMENT Market by its major segments, which include the type, end user industry, and the major geographic regions.
KEY BENEFITS OF THE REPORT:
Understanding of the strategies that are being adopted by the key players in this market to stay competitive
Extensive analysis of the key players dominating the competitive landscape of this market
In-depth analysis of the key factors are propelling the growth of the global market
Detailed analysis of the geographic region that will witness the strongest growth
Granular analysis of the current market scenario and the expected market grow
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
